tion, poor absorption of nutrients, dehydration, and augmented susceptibility to other infectious agents. The onset of clinical signs is mainly due to the fact that part of the life cycle of different Eimeria species occurs within intestinal cells, leading to modifications in mucosal structures, principally in the villi [2] . However, these signs are not pathognomonic, and may be mistaken for a series of manifestations of other enteric infirmities that afflict the species [3] .
The control and prevention of coccidiosis can be accomplished by means of anticoccidial drugs or by vaccine [1] . Currently, ionophore antibiotics are widely used in the control of the disease. Chemical compounds can also be used alternately with ionophores and live vaccines, thus taking part in programs for controlling the disease [4] . The use of anticoccidial drugs in the control and prevention of the disease may be considered an option of success, despite the growing pressure from the consumer market to diminish or even eliminate the use of pharmaceutical drugs in animal feed [5] .
As such, a pressing interest exists in moving away from chemotherapeutic control of coccidiosis in favor of nonmedicated forms of control, such as vaccination [6] . But, the utilization of live vaccines can be accompanied by intestinal lesions, brought about by the invasion and multiplication of parasites, and clinical signs with subsequent diminution of performance [6, 7] . However, in this manner, the use of live vaccines would not be advantageous; but according to some researchers [6, 8, 9] , vaccinated birds present compensatory BW gain in the period following vaccination, reaching the age of slaughter weighing as least as much as birds having been submitted to anticoccidial drugs. Given that context, the objective of the current research was to evaluate the effect of vaccination on turkey performance and intestinal morphology.
MATERIALS AND METHODS

Innoculum
oocysts used for clinical challenge were field-strain Eimeria isolated from commercial turkey-rearing houses. oocyst strains were droppings from thirty 21-d-old turkeys from 10 poultry houses in the southern region of Brazil. The inoculum was prepared according to the de-scription of Hammond and Long [10] . Oocysts were stored in a 2.5% potassium dichromate solution and then enumerated before challenge. Before use, the solution containing the oocysts was washed by centrifugation (1,500 × g for 5 min at room temperature), which was repeated 3 times. On d 21 of life, all birds of all treatments were challenged with a mixed-species containing E. meleagrimitis and E. galopavonis via crop intubation with 1 ml of ~20,000 sporulated oocysts/bird. The size of the inoculum was determined in previous experiments.
DNA Extraction and Identification of Eimeria Species
After recovery of oocysts from feces, the sample was washed in distilled water by centrifugation at 1,200 × g for 10 min at 4°C. Next, 300 µl of lysis buffer (12.5% Chelex 100 [11], 10 mM Tris, 10 mM EDTA, 1% BSA, and 5 µL of SDS 20%) was added to the sediment containing oocysts. The solution was submitted to thermal shock in liquid nitrogen and a warm bath at 95°C (1:3 min). Afterward, 20 µl of proteinase K (20 mg/ml) was added and incubated at temperature of 65°C for 2 h in a rotational incubator (1,000 × g) to release sporocysts. We used the QIAamp DNA Stool Mini Kit [12] to extract the DNA from sporocysts following the instructions of the manufacturer.
PCR
The primers WW1F (5′-AAG TTG CGT AAA TAG AGC CC 3′, specific genus) and WW3R (5′-CAA GAC ATC CAT TGC TGA AA-3′, specific order) were used to confirm the genus Eimeria [13] . Subsequently, the genus Eimeria was confirmed in the sample, with the confirmation of the species having been accomplished by using the primers described in Table 1 . Two commercial vaccines containing 4 species (E. meleagrimitis, E. adenoeides, E. gallopavonis, and E. dispersa) and another containing 2 species (E. meleagrimitis and E. adenoeides) were used as positive-control references strains.
Amplification reactions were performed in a DNA thermocycler (iCycler [11]) using primers manufactured by Invitrogen [14] . A standard 25-µL reaction volume consisted of 12.5 µL of Master Mix [15], 5 µL of DNA sample, 10 µM of each primer (forward and reverse), and 2.5 µl of nuclease-free water. Cycling conditions were 1 cycle at 95 C for 15 min, followed by 35 denaturation cycles at 95°C for 30 s, annealing at 55°C for 30 s and extension at 72°C for 30 s, then completed with a final extension at 72°C for 7 min. For each 10 µL of amplified product, 1 µl of running buffer was added [16] . The PCR products were visualized by loading 10 µl of the reaction on a 2% agarose gel [14] along with an appropriate DNA fragment size ladder [14] and the negative and positive controls. After a 50-min electrophoresis, the gel image was visualized under UV illumination. The molecular evidence enabled confirmation of primarily by the genus Eimeria through the primers WW1F and WW3R and secondarily by the species E. gallopavonis via the primers EgaF and EgaR and E. meleagrimitis by means of the primers Eme2F and Eme2R in the fecal samples collected (Table 1) .
Birds and Housing
Three hundred fifteen 1-d-old female commercial cross turkey poults (British United Turkeys, BUT Big 9) were obtained from a commercial hatchery. The poults were vaccinated, in a hatchery, against Newcastle disease and infectious rhinotracheitis. The procedures of housing, feed management, and daily care were similar for all the birds, as recommended by British United Turkeys [17] .
Turkey poults were randomly allocated in 3 experimental treatments for 10 wk. Each treatment had 105 poults arranged in 5 replicates of 21 birds each. The poults were housed in floor pens (5 m 2 ) with new wood shaving litter. Poults were initially maintained at 32°C and the temperature was gradually reduced by 3°C per week to reach a temperature of 21°C by the end of wk 4. This temperature was maintained for the duration of the experiment.
The pens were isolated via plastic sheeting and the use of equipment for individual protection (boots, gloves) were separated according to the treatment. The birds of the different groups were managed similarly, differing only in turning of the litter, which in the vaccinated group was done only on the 15th day after administration of vaccine, whereas in the other treatments this handling was performed weekly.
Experimental Design and Additives
Birds were fed a corn and soybean mealbased diet with the feed program being divided into 4 phases: starter (0-3 wk), grower (4-6 wk), developer (7-9 wk), and finisher (9-10 wk). Water and feed were supplied ad libitum. The experimental diets were formulated to meet or exceed the minimum nutrient requirements of turkeys according to the NRC [18] ( Table 2) . The diets were given as pellets throughout the experiment and none of the diets contained antibiotic growth promoters.
The experimental treatments received a cornsoybean meal basal diet and were a control diet, without vaccination against coccidiosis or anticoccidial drug, a diet supplemented with anticoccidial drug from 1 to 60 d of age, and the control diet and vaccination against coccidiosis with commercial vaccine. The anticoccidial 
Experimental Parameters Measured
Performance. Birds and feed were weighed by pen at d 21, 28, and 70 to determine average BW, BW gain, feed intake, and FCR. In addition, overall BW gain, feed intake, and FCR were calculated for the whole duration of the experiment (d 0-70). At 70 d, all birds from all groups were weighed individually to determine the coefficient of variation of BW. Mortalities were recorded daily and performance was corrected for mortality.
Intestinal Morphology. At 28 and 70 d of age, 10 birds per treatment (i.e., 2 birds/pen) were randomly selected and euthanized by the i.m. administration of 2 mg/kg of xylazine (pectoralis major), followed by the intravenous administration of 15 mg/kg of sodium thiopental. After the unconsciousness of bird was detected, 3 ml of potassium chloride was administered to induce death. The birds were necropsied and the intestinal segments were collected for measurement of intestinal villi. The segments were divided into duodenum, the portion from the pylorus to the distal duodenal loop; jejunum, from the distal part of the duodenal loop to the yolk sac diverticulum; ileum, from the diverticulum yolk to the cecum; and cecum, from the insert to its extremities. Fragments (2 cm) were removed from the medial portion of all previously mentioned segments. The fragments were immersed in 10% neutral-buffered formalin for 48 h, dehydrated with increasing concentrations of ethanol, cleared with 2 passages through xylol, and placed into paraffin plastic. The histological sections (5 µm) were stained with hematoxylin and eosin. The measurements of villus height were obtained through the analysis of images of histological sections made with the aid of a computerized image-capture system [19] . Measurements for villus height were taken from the tip of the villi to the valley between individual villi. The height of 15 villi from each segment was measured. The experimental protocol used was approved by the Ethics Committee on Animal Use (n°188/2007) of the Universidade Estadual Paulista "Júlio de Mesquita Filho," Botucatu Campus.
Statistical Analysis
The results for performance and length of the intestinal villi were submitted to ANoVA complemented with Tukey's test of multiple comparisons. All statements of statistical significance are based upon P < 0.05.
RESULTS AND DISCUSSION
Poult BW did not differ between the experimental treatments on d 1 (i.e., experimental start). At 21 d of age, the BW, BW gain, feed intake, FCR, and livability were not affected by treatments (Table 3 ). In the current study, vaccination did not adversely affect turkey performance. Tests involving the same commercial vaccine used in the current experiment had been previously conducted in flocks of commercial turkeys. Those authors [20-22] reported that Means followed by different letters within a row are significantly different (Tukey, 5%) ± SEM. 1 Control = control diet, without vaccination against coccidiosis or anticoccidial drug; Anticoccidial drug = diet supplemented with anticoccidial drug from the 1 to 60 d of age; Commercial vaccine = control diet and vaccination against coccidiosis with commercial vaccine.
Downloaded from https://academic.oup.com/japr/article-abstract/23/2/204/759777 by guest on 22 December 2018 vaccinated turkeys had no coccidial infection associated with vaccination. During the growth phase (d 0-28), after coccidiosis challenge, only the birds belonging to the control group presented clinical signs of diseases, such as diarrhea and prostration; no disease-provoked mortality was observed. It is known that the life cycle of Eimeria occurs in different regions of the intestine, resulting in damage to the intestinal cells. In turkeys, macroscopic lesions are sometimes not found in the intestinal mucosa, nor are clinical signs, contrary to chickens, in which the lesions are well defined and frequent. Although there are no lesions apparent in the mucosa, their absorptive capacity can be compromised severely, which results in greater FCR, lesser BW gain, and lower average BW [23] .
Body weight was influenced by coccidiosis challenge (P = 0.032; Table 3 ). Vaccinated turkeys presented average BW (984 g) 14.3% above that of control group (843 g), followed by those receiving the anticoccidial drug (1,021 g) with 17.4% above that of control group. on d 28 (d 0-28), turkeys of control group presented a BW gain lower than other groups (784 g; P = 0.029). The vaccinated turkeys (925 g) and medicated turkeys (961 g) presented similar BW gains. Therefore, the vaccinated turkeys were able to withstand to disease challenge, as the BW gain after coccidiosis challenge is one of the principle tools for evaluating the efficiency of the vaccination process, as well as the product used [5] . The turkeys that received the anticoccidial drug presented a BW gain 18.4% higher than control birds, and feed intake was not influenced negatively by the coccidiosis challenge.
During the growth phase (d 0-28), the control group presented higher FCR than the other groups (P = 0.041) until the 49th day, when stabilization of this index occurred and continued until slaughter age. According to Clarkson [24] , on the 14th day after moderate infection by E. meleagrimitis, the macroscopic aspect of the intestinal mucosa presents regeneration, whereas the performance indices tend to return to normality. The feed intake was not influenced by the administration of vaccine, anticoccidial drug, or coccidiosis challenge (P = 0.09). Throughout the rearing period (d 28-70), the control birds showed recovery of BW, BW gain, and FCR, and treatments had no significant effects on turkey performance traits.
The control group presented a higher CV of BW (12.3%) than birds from the other groups (P = 0.042; Table 3 ). The turkeys manifested clinical signs of coccidiosis after being challenged and, although performance had recovered rapidly, some birds did not attain the performance objectives, thereby reducing the uniformity index. No difference in villi height was observed between the treated groups and the control group at 27 and 70 d of age (Table 4 ). It was expected that shortening of the intestinal villi would occur soon after coccidiosis challenge, especially in the control group, which suffered a negative effect on performance. An electron micrograph (500×) of the duodenal screening of turkeys fed the control diet (without vaccination against coccidiosis or anticoccidial drug) revealed the lesions caused by coccidiosis as compared with the vaccinated turkeys ( Figure 1 ). It has been observed that the villi lose microvilli and suffer exposure of the tip. These conditions facilitate the entry of pathogenic agents, reduce the absorption of nutrients, and, consequently, diminish the performance of birds [2] .
During the whole experimental period (d 0-70), coccidiosis challenge and treatments had no significant effects on turkey performance. According to Chapman et al. [5] , due to the fact that live vaccines had been administered only one time, the reinfection, a consequence of ingesting vaccine oocysts from feces or even from nonvaccine oocysts present in the litter, is important for the formation of immunity, as it is not developed not only from the first application of the vaccine, but also from the ingestion of small doses of oocysts. The birds were exposed adequately to vaccine and the subsequent reinfections, necessary to the formation of immunity and subject to management procedures, succeeded satisfactorily, resulting in adequate performance.
CONCLUSIONS AND APPLICATIONS
1. Live oocyst vaccination had no significant effects on the BW, BW gain, feed intake, FCR, livability, and villus height. 2. The vaccine was able to protect birds against experimental coccidiosis challenge. 3. Live oocyst vaccination can be used effectively as a preventive against avian coccidiosis in commercially reared turkeys. 
